Scientific advances in understanding how to manipulate genes to alter the course of disease are now starting to bear fruit.
After a six-month delay due to the COVID-19 pandemic, the first provisions of the interoperability rule issued by the Centers for Medicare & Medicaid Services took effect on July 1.
As this decade begins, Americans are increasingly apprehensive about the privacy of their personal information.
In our recent CLE-eligible webinar, Manatt Health explored the range of legal changes to healthcare privacy that the COVID-19 pandemic is driving, including both immediate effects and long-term consequences.
The COVID-19 pandemic has quickly caused at least a temporary restructuring of the U.S. healthcare system.
The COVID-19 pandemic has quickly upended many aspects of the healthcare system, including enforcement of three important federal fraud and abuse laws: the physician self-referral law, commonly known as the “Stark law”; the Anti-Kickback Statute (AKS); and a civil monetary penalty ...
At the end of March, President Trump signed into law the third coronavirus stimulus legislation, a $2 trillion package known as the Coronavirus Aid, Relief, and Economic Security Act (CARES Act).
On Monday, the Centers for Medicare & Medicaid Services (CMS) released an interim final rule with comment period outlining new flexibilities to pre-existing Medicare and Medicaid payment policies and provider regulations in the midst of the COVID-19 public health emergency (PHE).
In its 2021 Proposed Rule for the Medicare Advantage program, the Centers for Medicare & Medicaid Services (CMS) proposes to alter the rules under which Medicare Advantage Organizations (MAOs) may obtain reinsurance.
The information blocking rule—now moved to the Office of Management and Budget (OMB), the last step before a rule is promulgated—is significant because it reverses the typical framework governing the privacy of health information.